Age-related macular degeneration: Non-neovascular early AMD, intermediate AMD, and geographic atrophy

Retina Fifth Edition

Volumn , Issue , 2012, Pages 1150-1182

  Bressler, Susan B ^a   Bressler, Neil M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903147999     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-0737-9.00065-5     Document Type: Chapter

References (158)

1. Ferris FL III., Senile macular degeneration: review of epidemiologic features Am J Epidemiol 118 1983 132-151.
2. The Age-Related Eye Disease Study Research Group Potential public health impact of AREDS results: AREDS report no. 11 Arch Ophthalmol 121 2003 1621-1624.
3. The Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 567-572.
4. Klein R., Klein BEK., Jensen SC., et al. The five-year incidence and progression of age-related maculopathy Ophthalmology 104 1997 7-21.
5. Evans J., Wormold R Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 80 1996 9-14.
6. Campbell JP., Bressler SB., Bressler NB Impact of availability of anti-VEGF therapy on vision impairment and blindness due to neovascular AMD Arch Ophthalmol 130 2012 794-795.
7. Gass JDM Drusen and disciform macular detachment and degeneration Arch Ophthalmol 90 1973 206-217.
8. Haab O Erkrankungen der Macula Lutea Centralblat Augenheilkd 9 1885 384-391 (Cited by Duke-Elder S. System of ophthalmology, vol. 9. London: Kimpton; 1966.).
9. Piguet B., Haimovici R., Bird AC Dominantly inherited drusen represent more than one disorder: a historical review Eye 9 1995 34-41.
10. Gass JDM Pathogenesis of disciform detachment of the neuroepithelium (parts I and III) Am J Ophthalmol 63 1967 573-711.
11. Bird AC., Bressler NB., Bressler SB., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration Surv Ophthalmol 39 1995 367-374.
12. Klein R., Klein BEK., Linton KLP Prevalence of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 99 1992 933-943.
13. The Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 Arch Ophthalmol 119 2001 1417-1436.
14. Mitchell P., Smith W., Attebo K., et al. Prevalence of age-related maculopathy in Australia Ophthalmology 102 1995 1450-1460.
15. Wang Q., Chappell RJ., Klein R., et al. Patterns of age-related maculopathy in the macular area, the Beaver Dam Eye Study Invest Ophthalmol Vis Sci 37 1996 2234-2242.
16. Vingerling JR., Dielemans I., Hofman A., et al. The prevalence of age-related maculopathy in the Rotterdam Study Ophthalmology 102 1995 205-210.
17. Wang JJ., Mitchell P., Smith W., et al. Bilateral involvement by age-related maculopathy lesions in a population, the Blue Mountains Eye Study Br J Ophthalmol 82 1998 743-747.
18. Bressler NM., Bressler SB., West SK., et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen Arch Ophthalmol 107 1989 847-852.
19. Gregor Z., Bird AC., Chisholm IH Senile disciform macular degeneration in the second eye Br J Ophthalmol 61 1977 141-147.
20. Klein R., Davis MD., Magli YL., et al. The Wisconsin age-related maculopathy grading system Ophthalmology 98 1991 1128-1134.
21. Green WR., McDonnell PJ., Yeo JH Pathologic features of senile macular degeneration Ophthalmology 92 1985 615-627.
22. Green WR., Enger C Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture Ophthalmology 100 1993 1519-1535.
23. Sarks SH Aging and degeneration in the macular region: a clinico-pathological study Br J Ophthalmol 60 1976 324-341.
24. Spraul CW., Grossniklaus HE Characteristics of drusen and Bruch’s membrane in postmortem eyes with age-related macular degeneration Arch Ophthalmol 115 1997 267-273.
25. van der Schaft TL., Mooy CM., de Bruijn WC., et al. Histologic features of the early stages of age-related macular degeneration. A statistical analysis Ophthalmology 99 1992 278-286.
26. Laatikainen L., Karinkari J Capillary-free area of the fovea with advancing age Invest Ophthalmol Vis Sci 161 1977 1154-1157.
27. Grunwald JE., Piltz J., Patel N., et al. Effect of aging on retinal macular microcirculation: a blue-field simulation study Invest Ophthalmol Vis Sci 34 1994 3609-3613.
28. Groh MJM., Michelson G., Langhans MJ., et al. Influence of age on retinal and optic nerve head blood circulation Ophthalmology 103 1996 529-534.
29. Ibrahim YWM., Bots ML., Mulder PGH., et al. Number of perifoveal vessels in aging, hypertension, and atherosclerosis: the Rotterdam Study Invest Ophthalmol Vis Sci 39 1998 1049-1053.
30. Gao H., Hollyfield JG Aging of the human retina: differential loss of neurons and retinal pigment epithelial cells Invest Ophthalmol Vis Sci 33 1992 1-17.
31. Rubin GS., West SK., Munoz B., et al. A comprehensive assessment of visual impairment in a population of older Americans, the SEE study Invest Ophthalmol Vis Sci 38 1977 557-568.
32. Sandberg MA., Gaudio AR Slow photostress recovery and disease severity in age-related macular degeneration Retina 15 1995 407-412.
33. Liem AT., Keunen JE., van Norren D Clinical applications of fundus reflection densitometry Surv Ophthalmol 41 1996 37-50.
34. Curcio CA., Millican CL., Allen KA., et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina Invest Ophthalmol Vis Sci 34 1993 3278-3296.
35. Dorey CK., Wu G., Ebenstein D., et al. Cell loss in the aging retina: relationship to lipofuscin accumulation and macular degeneration Invest Ophthalmol Vis Sci 30 1989 1691-1699.
36. Feeney-Burns L., Burns RP., Gao C Age-related macular changes in humans over 90 years old Am J Ophthalmol 109 1990 265-278.
37. Marshall J., Grindle J., Ansell PL., et al. Convolution in human rods: an ageing process Br J Ophthalmol 63 1979 181-187.
38. Curcio CA., Medeiros NE., Millican CL Photoreceptor loss in age-related macular degeneration Invest Ophthalmol Vis Sci 37 1996 1236-1249.
39. Young RW The Bowman Lecture, 1982. Biological renewal: applications to the eye Trans Ophthalmol Soc UK 102 1982 42-75.
40. Feeney-Burns L., Berman ER., Rothman H Lipofuscin of human retinal pigment epithelium Am J Ophthalmol 90 1980 783-791.
41. Young RW Pathophysiology of age-related macular degeneration Surv Ophthalmol 31 1987 291-306.
42. Rakoczy PE., Baines M., Kennedy C., et al. Correlation between autofluorescent debris accumulation and the presence of partially processed forms of cathepsin D in cultured retinal pigment epithelial cells challenged with rod outer segments Exp Eye Res 63 1996 159-167.
43. Feeney-Burns L., Hilderbrand ES., Eldridge S Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells Invest Ophthalmol Vis Sci 25 1984 195-200.
44. Beatty S., Boulton M., Henson D., et al. Macular pigment and age-related macular degeneration Br J Ophthalmol 83 1999 867-877.
45. Kennedy CJ., Rakoczy PE., Constable IJ Lipofuscin of the retinal pigment epithelium: a review Eye 9 1995 763-771.
46. von Ruckmann A., Fitzke FW., Bird AC In vivo fundus autofluorescence in macular dystrophies Arch Ophthalmol 115 1997 609-615.
47. Delori FC., Dorey CK., Staurenghi G., et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics Invest Ophthalmol Vis Sci 36 1995 718-729.
48. Panda-Jonas S., Jonas JB., Jakobczyk-Zmija M Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes Am J Ophthalmol 121 1996 181-189.
49. Gass JDM Stereoscopic atlas of macular diseases: diagnosis and treatment 4th ed 1997 Mosby St Louis.
50. Ramrattan RS., van der Schaft TL., Mooy CM., et al. Morphometric analysis of Bruch’s membrane, the choriocapillaris, and the choroid in aging Invest Ophthalmol Vis Sci 35 1994 2857-2864.
51. Karwatowski WSS., Jeffries TE., Duance VC., et al. Preparation of Bruch’s membrane and analysis of the age-related changes in the structural collagens Br J Ophthalmol 79 1995 944-952.
52. Holz FG., Owens SL., Marks J., et al. Ultrastructural findings in autosomal dominant drusen Arch Ophthalmol 115 1997 788-792.
53. van der Schaft TL., de Bruijn WC., Mooy CM., et al. Is basal laminar deposit unique for age-related macular degeneration? Arch Ophthalmol 109 1991 420-425.
54. Marshall GE., Konstas AGP., Reid GG., et al. Type IV collagen and laminin in Bruch’s membrane and basal linear deposit in the human macula Br J Ophthalmol 76 1992 607-614.
55. Feeney-Burns L., Ellersieck MR Age-related changes in the ultrastructure of Bruch’s membrane Am J Ophthalmol 100 1985 686-697.
56. Burns RP., Feeney-Burns L Clinico-morphologic correlations of drusen of Bruch’s membrane Trans Am Ophthalmol Soc 78 1980 206-225.
57. Ishibashi T., Sorgente N., Patterson R., et al. Aging changes in Bruch’s membrane of monkeys: an electron microscopic study Ophthalmologica 192 1986 179-190.
58. Killingsworth MC Age-related components of Bruch’s membrane in the human eye Graefes Arch Clin Exp Ophthalmol 225 1987 406-412.
59. Holz FG., Sheraidah G., Pauleikhoff D., et al. Analysis of lipid deposits extracted from human macular and peripheral Bruch’s membrane Arch Ophthalmol 112 1994 402-406.
60. Klein R., Klein BEK., Jensen SC., et al. The relationship of ocular factors to the incidence and progression of age-related maculopathy Arch Ophthalmol 116 1998 506-513.
61. Sheraidah G., Steinmetz R., Maguire J., et al. Correlation between lipids extracted from Bruch’s membrane and age Ophthalmology 100 1993 47-52.
62. Pauleikhoff D., Harper CA., Marshall J., et al. Aging changes in Bruch’s membrane: a histochemical and morphologic study Ophthalmology 97 1990 171-178.
63. Spaide RF., Ho-Spaide WC., Browne R., et al. Characterization of peroxidized lipids in Bruch’s membrane Retina 19 1999 141-147.
64. Holz FG., Bellmann C., Margaritidis M., et al. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy associated with age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 237 1999 145-152.
65. Moore DJ., Hussain AA., Marshall J Age-related variation in the hydraulic conductivity of Bruch’s membrane Invest Ophthalmol Vis Sci 36 1995 1290-1297.
66. Starita C., Hussain AA., Patmore A., et al. Localization of the site of major resistance to fluid transport in Bruch’s membrane Invest Ophthalmol Vis Sci 38 1997 762-767.
67. In: Marshall J., Hussain AA., Starita C., et al. The retinal pigment epithelium: function and disease 1998 Oxford University Press New York.
68. Grunwald JE., Hariprasad SM., Dupont J Effect of aging on foveolar choroidal circulation Arch Ophthalmol 116 1998 150-154.
69. Curcio CA., Millican CL Basal linear deposit and large drusen are specific for early age-related maculopathy Arch Ophthalmol 117 1999 329-339.
70. Zarbin MA Age-related macular degeneration: review of pathogenesis Eur J Ophthalmol 8 1998 199-206.
71. Löffler KU., Lee WR Basal linear deposit in the human macula Graefes Arch Clin Exp Ophthalmol 224 1986 493-501.
72. van der Schaft TL., Mooy CM., de Bruijn WC., et al. Immunohistochemical light and electron microscopy of basal laminar deposit Graefes Arch Clin Exp Ophthalmol 232 1994 40-46.
73. Sarks JP., Sarks SH., Killingsworth MC Evolution of soft drusen in age-related macular degeneration Eye 8 1994 269-283.
74. Green WR., Key SN III., Senile macular degeneration: a histopathologic study Trans Am Ophthalmol Soc 75 1977 180-254.
75. Bressler NM., Silva JC., Bressler SB., et al. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration Retina 14 1994 130-142.
76. El Baba F., Green WR., Fleischmann J., et al. Clinicopathologic correlation of lipidization and detachment of the retinal pigment epithelium Am J Ophthalmol 101 1986 576-583.
77. Shuman SG., Koreishi AF., Farsui S., et al. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with sepctral-domain optical coherence tomography Ophthalmology 116 2009 488-496.
78. Pieroni CG., Witkin AJ., Ko TH., et al. Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration Br J Ophthalmolo 90 2006 191-197.
79. Ho J., Witkin AJ., Liu J., et al. Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography Ophthalmology 118 2011 687-693.
80. Sarks JP., Sarks SH., Killingsworth M Evolution of geographic atrophy of the retinal pigment epithelium Eye 2 1988 552-577.
81. Penfold PL., Killingsworth MC., Sarks SH Senile macular degeneration: the involvement of immunocompetent cells Graefes Arch Clin Exp Ophthalmol 223 1985 69-76.
82. Sarks JP., Sarks SH., Killingsworth MC Morphology of early choroidal neovascularisation in age-related macular degeneration Eye 11 1997 515-522.
83. Killingsworth MC., Sarks JP., Sarks SH Macrophages related to Bruch’s membrane in age-related macular degeneration Eye 4 1990 613-621.
84. The Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17 Arch Ophthalmol. 123 2005 1484-1498.
85. Eye Disease Case-Control Study Group Risk factors for neovascular age-related macular degeneration Arch Ophthalmol 110 1992 1701-1708.
86. Macular Photocoagulation Study Group Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration Arch Ophthalmol 115 1997 741-747.
87. Bressler NM., Bressler SB., Seddon JM., et al. Drusen characteristics in patients with exudative versus nonexudative age-related macular degeneration Retina 8 1988 108-114.
88. The Age-Related Eye Disease Study Research Group A simplified severity scale for age-related macular degeneration: AREDS no. 18 Arch Ophthalmol 123 2005 1570-1574.
89. Barondes M., Pauleikhoff D., Chisholm IC., et al. Bilaterality of drusen Br J Ophthalmol 74 1990 180-182.
90. Friedman D., Parker JS., Kimble JA., et al. Quantification of fluorescein-stained drusen associated with age-related macular degeneration Retina 31 10 2011 1-6.
91. Chang AA., Guyer DR., Orlock DR., et al. Age-dependent variations in the drusen fluorescence on indocyanine green angiography Clin Experiment Ophthalmol 31 4 2003 300-304.
92. Arnold JJ., Quaranta M., Soubrane G., et al. Indocyanine green angiography of drusen Am J Ophthalmol 124 1997 344-356.
93. Delori FC., Fleckner MR., Goger DG., et al. Autofluorescence distribution associated with drusen in age-related macular degeneration Invest Ophthalmol Vis Sci 41 2 2000 496-504.
94. Khanifar AA., Koreishi AF., Izatt JA., et al. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration Ophthalmology 115 2008 1883-1890.
95. Schlanitz FG., Baumann B., Spaliek T., et al. Performance of automated drusen detection by polarization-sensitive optical coherence tomography Invest Ophthalmol Vis Sci 51 2011 4571-4579.
96. Jain N., Farsiu S., Khanifar AA., et al. Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs Invest Ophthalmol Vis Sci 51 2010 4875-4883.
97. Gass JDM., Jallow S., Davis B Adult vitelliform macular detachment occurring in patients with basal laminar drusen Am J Ophthalmol 99 1985 445-459.
98. Sarks SH., Arnold JJ., Killinsworth MC., et al. Early drusen formation in the normal and aging eye and their relationship to age-related maculopathy: a clinicopathological study Br J Ophthalmol 83 1999 358-368.
99. Hageman GS., Mullins RF Molecular composition of drusen as related to substructural phenotype Mol Vis 5 1999 28-37.
100. Coffey AJH., Brownstein S The prevalence of macular drusen in postmortem eyes Am J Ophthalmol 102 1986 164-171.
101. Bressler NM., Munoz B., Maguire MG., et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities, Chesapeake Bay watermen study Arch Ophthalmol 113 1995 301-308.
102. Sarks SH Drusen and their relationship to senile macular degeneration Aust J Ophthalmol 8 1980 117-130.
103. Bird AC Pathogenesis of retinal pigment epithelial detachment in the elderly: the relevance of Bruch’s membrane change: Doyne lecture Eye 5 1991 1-12.
104. Casswell AG., Kohen D., Bird AC Retinal pigment epithelial detachments in the elderly: classification and outcome Br J Ophthalmol 69 1985 397-403.
105. Hartnett ME., Weiter JJ., Garsd A., et al. Classification of retinal pigment epithelial detachments associated with drusen Graefes Arch Clin Exp Ophthalmol 230 1992 11-19.
106. Holz FG., Wolfensberger TJ., Piguet B., et al. Bilateral macular drusen in age-related macular degeneration: prognosis and risk factors Ophthalmology 101 1994 1522-1528.
107. Cukras C., Agron E., Klein ML., et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28 for the Age-Related Eye Disease Study Research Group Ophthalmology 117 2010 489-499.
108. Complications of Age-Related Macular Degeneration Prevention Trial Research Group Laser treatment in patients with bilateral large drusen. The Complications of Age-Related Macular Degeneration Prevention Trial Ophthalmology 113 2006 1974-1986.
109. Arnold JJ., Sarks SH., Killingsworth MC., et al. Reticular pseudodrusen: a risk factor in age-related maculopathy Retina 15 1995 183-191.
110. Zweifel SA., Spaide RF., Curio CA., et al. Reticular pseudodrusen are subretinal deposits Ophthalmology 117 2010 303-312.
111. Zweifel SA., Imamura Y., Spaide TC., et al. Prevalence and significance of subretinal drusenoid deposits (reticular psuedodrusen) in age-related macular degeneration Ophthalmology 117 2010 1775-1781.
112. Rudolf M., Malek G., Messinge JD., et al. Sub-retinal drusenoid deposits in human retina: organization and composition Exp Eye Res 87 2008 402-408.
113. Pumariega NM., Smith RT., Sohrab MA., et al. A prospective study of reticular macular disease Ophthalmology 118 8 2011 1619-1626.
114. Sarraf D., Gin T., Yu F., et al. Long-term drusen study Retina 19 1999 513-519.
115. Pauleikhoff D., Zuels S., Sheraidah GS., et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch’s membrane Ophthalmology 99 1992 1548-1553.
116. Mullins RF., Johnson LV., Anderson DH., et al. Characterization of drusen-associated glycoconjugates Ophthalmology 104 1998 288-298.
117. Mullins RF., Hageman GS Human ocular drusen possess novel core domains with a distinct carbohydrate composition J Histochem Cytochem 47 1999 1533-1539.
118. Hageman GS., Mullins RF., Russell SR., et al. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells FASEB J 13 1999 477-484.
119. Schmitz-Valckenberg A., Fleckenstein M., Scholl H., et al. Fundus autofluorescence and progression of age-related macular degeneration Surv Ophthalmol 54 2009 96-117.
120. Berenberg TL., Metelitsina TI., Madow B., et al. The association between drusen extent and foveolar choroidal bloodflow in age-related macular degeneration Retina 31 10 2011 1-7.
121. McLeod DS., Lutty GA High-resolution histologic analysis of the human choroidal vasculature Invest Ophthalmol Vis Sci 35 1994 3799-3811.
122. Pauleikhoff D., Chen JC., Chisholm IH., et al. Choroidal perfusion abnormality with age-related Bruch’s membrane change Ophthalmology 109 1990 211-217.
123. Staurenghi G., Bottoni F., Lonati C., et al. Drusen and choroidal filling defects: a cross-sectional survey Ophthalmologica 205 1992 178-186.
124. Pauleikhoff D., Spital M., Radermacher M., et al. Regression of the choriocapillaris in age-related macular degeneration Invest Ophthalmol Vis Sci 38 Suppl. 1997 967.
125. Henkind P., Gartner S The relationship between retinal pigment epithelium and the choriocapillaris Trans Ophthalmol Soc UK 103 1983 444-447.
126. Glaser BM Extracellular modulating factors and the control of intraocular neovascularization Arch Ophthalmol 106 1988 603-607.
127. Friedman E., Krupsky S., Lane AM., et al. Ocular blood flow velocity in age-related macular degeneration Ophthalmology 102 1995 640-646.
128. Chen JC., Fitzke FW., Pauleikhoff D., et al. Functional loss in age-related Bruch’s membrane change with choroidal perfusion defect Invest Ophthalmol Vis Sci 33 1992 334-340.
129. Steinmetz RL., Haimovici R., Jubb C., et al. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch’s membrane change Br J Ophthalmol 77 1993 549-554.
130. Remulla JFC., Gaudio AR., Miller S., et al. Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration Br J Ophthalmol 79 1995 558-561.
131. Piguet B., Palmvang TB., Chisholm IH., et al. Evolution of age-related macular degeneration with choroidal perfusion abnormality Am J Ophthalmol 113 1992 657-663.
132. Sunness JS., Massof RW., Johnson MA., et al. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration Ophthalmology 96 1989 375-381.
133. Sunness JS., Johnson MA., Massof RW., et al. Retinal sensitivity over drusen and nondrusen areas: a study using fundus perimetry Arch Ophthalmol 106 1988 1081-1084.
134. Schatz H., McDonald HR Atrophic macular degeneration: rate of spread of geographic atrophy and visual loss Ophthalmology 96 1989 1541-1551.
135. Sunness JS., Rubin GS., Applegate CA., et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity Ophthalmology 104 1997 1677-1691.
136. Maguire P., Vine AK Geographic atrophy of the retinal pigment epithelium Am J Ophthalmol 102 1986 621-625.
137. Sunness JS., Applegate CA., Haselwood D., et al. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt’s disease Ophthalmology 103 1996 1458-1466.
138. Weiter JJ., Delori F., Dorey CK Central sparing in annular macular degeneration Am J Ophthalmol 106 1988 286-292.
139. Snodderly DM Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins Am J Clin Nutr 62 Suppl 1995 1448-1461.
140. Klein MK., Ferris FL., Armstrong J., et al. AREDS Research Group. Retinal precursors and the development of geographic atrophy in age-related macular degeneration Ophthalmology 115 2008 1026-1031.
141. Fleckenstein M., Schmitz-Valckenberg S., Adrion C., et al. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration Invest Ophthalmol Vis Sci 51 2010 3846-3852.
142. Klein R., Klein BE., Knudston MD., et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study Ophthalmology 114 2007 253-262.
143. Hyman LG., Lilienfeld AM., Ferris FL III., et al. Senile macular degeneration: a case-control study Am J Epidemiol 118 1983 213-227.
144. Sunness JS., Gonzalez-Baron J., Applegate CA., et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration Ophthalmology 106 1999 1768-1779.
145. AREDS Research Group Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report no. 26 Arch Ophthalmol 127 9 2009 1168-1174.
146. Sunness JS., Gonzalez-Baron J., Bressler NM., et al. The development of choroidal neovascularization in eyes with geographic atrophy form of age-related macular degeneration Ophthalmology 106 1999 910-919.
147. Forooghian F., Agron E., Clemons TE., et al. for the AREDS Research Group. Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: Age-Related Eye Disease Study report no. 27 Ophthalmology 116 2009 2093-2100.
148. Rosenfeld PJ., Shapiro H., Ehrlich JA., et al. on behalf of the MARINA and ANCHOR Study Groups. Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA Trials Am J Ophthalmol 152 2011 793-798.
149. Wang JJ., Klein R., Smith W., et al. Cataract surgery and the 5-year incidenceof late-stage age-related maculopathy. Pooled findings form the Beaver Dam and Blue Mountains Eye Studies Ophthalmology 110 2003 1960-1967.
150. Chew EY., Sperduto RD., Milton RC., et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report no. 25 Ophthalmology 116 2009 297-303.
151. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1994 1029-1035.
152. Omenn GS., Goodman GE., Thornquist MD., et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial J Natl Cancer Inst 88 21 1996 1550-1559.
153. Fine AM., Elman MJ., Ebert JE., et al. Earliest symptoms caused by neovascular membranes in the macula Arch Ophthalmol 104 1986 513-514.
154. Achard OA., Safran AB., Duret FC., et al. Role of the completion phenomenon in the evaluation of Amsler grid results Am J Ophthalmol 120 1995 322-329.
155. Schuchard RA Validity and interpretation of Amsler grid report Arch Ophthalmol 111 1993 776-780.
156. Goldstein M., Loewenstein A., Barak A., et al. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration Retina 25 2005 296-303.
157. Preferential Hyperacuity Perimetry (PHP) Research Group Preferential Hyperacuity Perimeter (PreView PHPTM) for detecting choroidal neovascularization study Ophthalmology 112 2005 1758-1765.
158. Lai Y., Grattan J., Shi Y., et al. Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter Retina 31 8 2011 1620-1626.